Zafrens is a startup based in the United States, 2 tracked investors.
Based in the United States, Zafrens is a startup. Brouky records 2 investors associated with the company.
Zafrens develops a benchtop high-throughput screening platform that integrates longitudinal cellular imaging with mRNA sequencing at single-cell resolution, enabling large-scale mapping of causal relationships in biology for applications such as drug discovery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.